These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21496695)

  • 1. The cutaneous effects of post-transplant immunosuppression with cyclosporine in Muir-Torre syndrome.
    Griffard EA; McCoppin HH; Wieberg J; Feldman M
    J Am Acad Dermatol; 2011 May; 64(5):e86-7. PubMed ID: 21496695
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
    Russ G; Jamieson N; Oberbauer R; Arias M; Murgia MG; Blancho G; Sato R; Stoeckl M; Revicki DA
    Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppression with sirolimus so donor kidneys survive longer].
    MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen.
    Kahan BD; Podbielski J; Schoenberg L
    Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Kahan BD
    Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus improves renal function in cardiac transplantation.
    Cabezón S; Lage E; Hinojosa R; Ordóñez A; Campos A
    Transplant Proc; 2005 Apr; 37(3):1546-7. PubMed ID: 15866668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.
    Kadikoy H; Paolini M; Achkar K; Suki W; Gaber AO; Anwar N; Jeroudi A; Barrios R; Abdellatif A
    Nephrol Dial Transplant; 2010 Aug; 25(8):2795-8. PubMed ID: 20484303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational clinical regimens for kidney transplant immunosuppression.
    Belitsky P
    Transplant Proc; 1994 Oct; 26(5):2485-9. PubMed ID: 7940763
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
    Granger DK; Cromwell JW; Canafax DM; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.
    Mohsin N; Budruddin M; Kamble P; Khalil M; Pakkyarra A; Jha A; Mohammed E; Ahmed H; Ahmed J; Thomas S; Campistol JM; Daar A
    Transplant Proc; 2007 May; 39(4):1267-71. PubMed ID: 17524950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H; Morelon E; Noel LH; Mamzer-Bruneel MF; Legendre C; Peraldi MN; Kreis H
    Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient.
    Falk JA; Cordova FC; Popescu A; Tatarian G; Criner GJ
    J Heart Lung Transplant; 2006 Jan; 25(1):140-3. PubMed ID: 16399546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
    Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
    Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.